Atlas Trials

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

Clinical trial NCT05901831 · COMPLETED

Trial details

NCT number
NCT05901831
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Kidney DiseaseType 1 Diabetes Mellitus
Start date
2024-02-26
Primary completion
2025-08-20
Enrollment
241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.